Invited speakers

Francis Chan

Duke University School of Medicine, UK

Necroptosis kinases in anti-viral immunity and tissue homeostasis

Jochen Prehn

Royal College of Surgeons, Dublin, Ireland

When one cancer cells enters another: TRAIL-induced entosis, cell death and mechanisms of escape

Tania Watts

University of Toronto, Canada

TNFR family members and signal 4: a checkpoint for T cell survival and tissue resident memory formation in the tissues

Mads Gyrd-Hansen

Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK

Regulation of innate immune signalling by the deubiquitinase CYLD

Stephanie Kreis

University of Luxembourg, Luxembourg

How to kill drug-resistant melanoma cells

Edward Mocarski

Emory University, Atlanta, USA

Inflammatory Consequences of Cell Death Pathways Suppressed by Herpesviruses

Douglas Green

St. Jude Children's Research Hospital, Memphis, USA

LC3-associated endocytosis (LANDO):  A noncanonical function of autophagy proteins regulates microglial activation and neurodegenerative disease

Pedro Friedmann-Angeli

University of Würzburg, Germany

Characterization of a novel mechanism of ferroptosis suppression

Bart Tummers

St. Jude Children's Research Hospital, Memphis, USA

FADD, caspase-8, MLKL, and inflammasome interactions in the control of lethal inflammation

Andreas Villunger

Medical University of Innsbruck, Austria

Caspase-2, a versatile protease of unknown significance

Patricia Boya

Spanish National Research Council (CSIC), Madrid, Spain

New links between autophagy and cell death

Seamus Martin

Trinity College Dublin, Ireland

The interplay between Cell Stress, Cell Death and Inflammation

Tom Vanden Berghe

University of Antwerp and Ghent University, Belgium

Ferroptosis targeting in multi-organ injury

Richard Kitsis
Albert Einstein College of Medicine
Bronx, New York, USA

Chemical, structural, and molecular approaches to inhibiting apoptotic and necrotic cell death

Peter Czabotar

The WEHI of Medical Research, Melbourne, Australia

Creating a Killer: Conversion of Bax and Bak into Membrane Permeabilising Executioners

Gerry Melino

MRC Toxicology Unit, Cambridge, UK

ZNF281 contributes to the DNA damage response as well as to neuronal differentiation and is a prognostic maker for neuroblastoma

Inna Lavrik

University of Madgeburg, Germany

Targeting CD95 DISC by systems and computational biology approaches to delineate the life/death decision in cancer cells

Mathieu Bertrand

VIB-UGent Center for Inflammation Research, Ghent, Belgium

Inhibition of RIPK1 kinase-dependent cell death by phosphorylation

Feng Shao

National Institute of Biological Science, Beijing, China

Mechanism and function of Gasdermin-mediated pyroptosis

Cristina Munoz Pinedo

IDIBELL Bellvitge Biomedical Research Institute, Barcelona, Spain

Cell death independent effects of metabolic stress


Carlo Croce

The Ohio State University, USA

MicroRNA dysregulation to identify targets for therapy in cancer

Shigekazu Nagata

Osaka University, Japan

Exposure of phosphatidylserine and efferocytosis

Mads Daugaard

University of British Columbia, Vancouver, Canada

Glycosaminoglycans as targets for cancer therapy

Brent Stockwell

Columbia University, NY, USA

Ferroptosis: Mechanisms and Therapeutic Applications

Sudan He

Chinese Academy of Medical Sciences, Suzhou, China

Modulation of the tumor microenvironment by necroptosis regulators

Kevin Ryan

Beatson Institute, Glasgow, UK

Cell Death in Cancer

Judy Lieberman

Harvard Medical School, Boston, USA


Microptosis: Programmed Cell Death in Microbes Activated by Killer Lymphocytes

Peter Vandenabeele

VIB-UGent Center for Inflammation Research, Ghent, Belgium

Comparative analysis of immunogenic cell death (ICD) by apoptosis, necroptosis and ferroptosis

William Kaiser

UT Health San Antonio, USA


Junying Yuan

Harvard Medical School, Boston, USA

The role of RIPK1 in mediating neurodegeneration

Scott Lowe

Memorial Sloan Kettering Cancer Center, NY, USA

Restoring tumor suppression to advanced cancers

Alexei Degterev

Tufts University, Boston, USA

Small molecule inhibitors of RIPK kinases

Carol Prives

Columbia University, NY, USA

Mdm2: master of life or master of death